News
Checkpoint inhibitor rechallenge is possible for select patients
- Author:
- Mary Jo Dales
Publish date: June 6, 2019
News

FDA approves abemaciclib plus aromatase inhibitor as initial therapy
- Author:
- Mary Jo Dales
Publish date: February 26, 2018
News
Imfinzi approved for stage III unresectable NSCLC
- Author:
- Mary Jo Dales
Publish date: February 17, 2018
News

Only half of appropriate COPD patients get long-acting bronchodilators
- Author:
- Mary Jo Dales
Publish date: October 25, 2017
News
Lomitapide manufacturer will plead guilty to two misdemeanor charges of misbranding
- Author:
- Mary Jo Dales
Publish date: September 23, 2017
News
Polycythemia vera test detects JAK2 V617F/G1849T mutation
- Author:
- Mary Jo Dales
Publish date: April 7, 2017
Article

VIDEO: CPX-351 may allow more high-risk AML patients to have allogeneic transplants
- Author:
- Mary Jo Dales
Publish date: December 4, 2016
Article
Factor VIII microcapsules eyed for eluding neutralizing antibodies
- Author:
- Mary Jo Dales
Publish date: November 11, 2016
Article

Investigational AML drugs boosted remission rates
- Author:
- Mary Jo Dales
Publish date: November 9, 2016
Article

Oxygen therapy no advantage in stable COPD with moderate desaturation
- Author:
- Mary Jo Dales
Publish date: October 26, 2016
Article
Age of blood did not affect mortality in transfused patients
- Author:
- Mary Jo Dales
Publish date: October 24, 2016
Article
Minimal residual disease status predicts 10-year survival in CLL
- Author:
- Mary Jo Dales
Publish date: October 13, 2016
Article

CD49d trumps novel recurrent mutations for predicting overall survival in CLL
- Author:
- Mary Jo Dales
Publish date: October 13, 2016
News
VTE risk appears to vary over time in patients with multiple myeloma
- Author:
- Mary Jo Dales
Publish date: August 12, 2016
News

Quality of life measures comparable for panobinostat or placebo in combination with bortezomib and dexamethasone
- Author:
- Mary Jo Dales
Publish date: August 11, 2016